| Lot Release Number |
2021-07-28-0375
|
| FDA Registered Product/Generic Name |
INFLIXIMAB
|
| Brand Name |
REMICADE
|
| Dosage Strength |
100 mg
|
| Dosage Form |
POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION (I.V.)
|
| Registration Number |
BR-1095
|
| Batch/Lot Number |
LCM17013A
|
| Packaging Lot |
Packaging Lot (Box): LCM17013; (Vial): LCM17013
|
| Product Expiration Date |
28 February 2024
|
| Issuance Date |
30 July 2021
|